Lycopodium Ltd (OTCPK:LYOPF)

Full Year 2026 Lycopodium Ltd Earnings Call Transcript

Aug 18, 2026 / 01:00 AM GMT

Release Date Price: $13.17

Transcript

Key Points

Positve

Lycopodium Ltd (LYOPF) delivered record revenue of $377.5 million, up 11% year-over-year, with NPAT of $40.2 million at the top end of guidance.
The company has a record level of committed work, with just under 70% of FY27 revenue guidance already secured, providing strong earnings visibility.
Lycopodium Ltd (LYOPF) is expanding its geographic diversification, highlighted by its first material full EPCM award in South America (Monera San Cristabel project in Bolivia).
The study pipeline has more than doubled since December, with over 90 studies currently underway, indicating a robust future project pipeline.
The company maintains a strong balance sheet with $106.2 million in cash and minimal debt, supporting its capital-light business model and dividend payments.
Management provided early FY27 guidance for revenue of $540-$580 million and NPAT of $54-$58 million, reflecting high confidence in continued growth.

Negative

Lycopodium Ltd (LYOPF)'s revenue is heavily concentrated in Africa (58%), exposing the company to potential sovereign and execution risks in those jurisdictions.
The company's FY27 revenue guidance implies a significant 50% year-on-year growth, with over 30% of the target still dependent on projects that have not yet formally committed.
Rapid expansion in the Americas requires additional investment in office space and headcount in Toronto, Vancouver, and Lima, which could pressure short-term margins.
The company faces execution risks on large, complex projects like the Blackwater Phase 2 expansion, which management acknowledged will come with challenges.
While the study pipeline is strong, conversion to project awards is not guaranteed, with management noting that only about 70% of advanced studies typically convert to execution work.
The business is scaling up its workforce (from 1,400 to 1,500 employees) to meet demand, which could lead to cost overruns or inefficiencies if growth is not managed carefully.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LYL.AX - Lycopodium Ltd
Full Year 2026 Lycopodium Ltd Earnings Call
Aug 19, 2026 / 01:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone, and welcome to the Lyca Podium Full Year FY26 Results Call. I'm Sam Wells from NWR Communications and joining me from the company today is Managing Director and CEO Peter DeLeo, as well as CFO Justine Campbell.

Following the summary of the results released to the market this morning, investors and research analysts will have an opportunity to ask questions throughout the call duration today.

There will be a choice of two. Options. First, analysts and investors can raise your hand via Teams should you wish to ask a verbal question of the management team, or you can also submit a written question via the Q&A function at the bottom of your screen.

If you are joining from your mobile

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.